


Aurora Clinical K.K. Revenue
Biotechnology Research • Ebisu-Minami 1-1-1, Shibuya-ku, Japan • 1-10 Employees
Aurora Clinical K.K. revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Aurora Clinical K.K.
Austin Westerman-Gritli
Senior Director, Clinical Program Management
Company overview
| Headquarters | Ebisu-Minami 1-1-1, Shibuya-ku, Humax Ebisu Bldg. 8F, Tokyo, JP |
| Website | |
| NAICS | 541714 |
| Keywords | Rare Disease, Clinical Development Strategy, Bilingual Project Management, Pmda Consultation, In-Country Clinical Caretaker (Iccc), Orphan Drug Designation (Odd), Protocol Development Support, Regulatory Affairs (Japan / Pmda) |
| Founded | 2025 |
| Employees | 1-10 |
About Aurora Clinical K.K.
Aurora Clinical K.K is a Japan-based partner for biotech and pharma companies looking to expand clinical development into Japan. We specialize in Japan-specific clinical program management, offering in-country clinical caretaker (ICCC) services under J-GCP, regulatory strategy consulting, and KOL engagement. With bilingual experts, deep cultural insight, and scientific rigor, we help you accelerate your Japan strategy.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Aurora Clinical K.K. has never raised funding before.
Frequently asked questions
4.8
40,000 users



